ALHC$19.22
$19.8669
Chart
Performance
Key Stats
AI ALHC Summary
Powered by LiveAIAI Scoreboard
Powered by LiveAIOverall Analysis
BuyAlignment Healthcare demonstrates potential for growth, supported by its healthcare platform for seniors. However, its recent performance and current valuation warrant careful consideration, with technical indicators suggesting a cautious short-term outlook.
Thematic
Alignment Healthcare operates in the growing Medicare Advantage sector, offering a demographic tailwind. However, its growth is dependent on healthcare policy and competitive pressures within the sector.
Fundamental
Alignment Healthcare shows robust revenue growth, but profitability remains a challenge with consistent net losses. The company maintains a solid cash position, but debt levels have increased.
Technical
The stock is experiencing a significant downturn, trading well below its key moving averages and showing predominantly 'Sell' signals across most technical indicators, suggesting strong downward momentum.
| Factor | Score |
|---|---|
| Aging Population & Medicare Advantage Growth | 80 |
| Healthcare Regulation & Policy Changes | 50 |
| Competitive Landscape | 60 |
| Platform Scalability and Innovation | 70 |
| Financial Performance Trends | 50 |
| Factor | Score |
|---|---|
| Valuation | 60 |
| Profitability | 20 |
| Growth | 90 |
| Balance Sheet Health | 30 |
| Cash Flow | 50 |
| Factor | Score |
|---|---|
| Trend Analysis | 20 |
| Momentum | 30 |
| Volume Confirmation | 50 |
| Support & Resistance | 70 |
AI Investing Checklist
Powered by LiveAIBullish Points (6)
Revenue Growth and Membership Expansion
Alignment Healthcare reported Q1 2025 revenue of $926.9 million, a 47.5% increase year-over-year, driven by a 31.7% rise in membership to 217,500 enrollees. The company also exceeded its high-end guidance for the quarter.
Positive Analyst Outlook
The average 12-month price target from analysts is around $16.80 to $17.17, suggesting a potential upside of 35-40% from the current trading price. The consensus rating is generally a 'Buy' or 'Moderate Buy'.
Bearish Points (6)
Continued Net Losses
Despite significant revenue growth, Alignment Healthcare continues to report net losses, with a net loss of $9.4 million in Q1 2025 and a net loss per share of five cents.
Negative Operating and Net Margins
The company has negative operating margins (-4.73% TTM) and net margins (-3.02% TTM), indicating that costs are exceeding revenue generation.
Calendar
July 2025
31
Next Earnings Date
H: $0.02
A: $-0.01
L: $-0.08
H: 965.00M
A: 960.25M
L: 955.30M
Profile
Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. The company was founded in 2013 and is based in Orange, California.
Seasonals
Price Target
18.22 USD
The 39 analysts offering 1 year price forecasts for ALHC have a max estimate of 22.00 and a min estimate of 9.00.
Debt Level and Coverage
Financial Position Analysis
Ownership
Capital Structure
Valuation - Summary
Valuation - Ratios
Revenue to Profit Conversion
Balance Sheet
Income Statement
Cash Flow
Related Companies
Powered by LiveAIWeight: 95
Largest diversified healthcare company with a massive Medicare Advantage presence and integrated health services through Optum, making it a primary competitor and industry benchmark.
Weight: 90
One of the largest and most dedicated Medicare Advantage providers in the U.S., directly competing with ALHC for senior members.
Weight: 88
Owns Aetna, a major Medicare Advantage insurer, and integrates pharmacy benefits and retail clinics, offering a broad consumer-centric healthcare approach.
Weight: 85
Large health benefits company with a significant and growing presence in Medicare Advantage plans across numerous states.